Wednesday, November 6, 2019

Aurobindo Pharma gets 8 observations for 2 plants from USFDA

Aurobindo Pharma gets 8 observations for 2 plants from USFDA The USFDA inspected active pharmaceutical ingredients (API) manufacturing facility (Unit V) at Pashamylaram and API manufacturing facility (Unit VIII) at Gaddapotharam in Hyderabad between October 21 and October 28, the company said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2PSHuLM
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL Tech

Indian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Sever...